Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G M Rodgers

Showing results (21-30 of 106) with videos related to

Pageof 11
Sort By:
American Journal of Clinical Pathology|August 1, 1996
Utilization of testing for activated protein C resistance in a reference laboratoryS R Florell, G M Rodgers
American Journal of Hematology|September 2, 1998
Disseminated intravascular coagulation: clinical and laboratory aspectsM J Carey, G M Rodgers
American Journal of Hematology|October 1, 1992
Laboratory and clinical aspects of inherited thrombotic disordersG M Rodgers, W L Chandler
Journal of Thrombosis and Haemostasis : JTH|April 29, 2015
Acute renal failure is prevalent in patients with thrombotic thrombocytopenic purpura associated with low plasma ADAMTS13 activity: commentM J Bentley, G M Rodgers
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1983
Prothrombin is activated on vascular endothelial cells by factor Xa and calciumG M Rodgers, M A Shuman
American Journal of Hematology|August 1, 1991
Lack of response to commercial factor VIII concentrate in hemophilia AG M Rodgers, M H Ford
American Journal of Hematology|January 1, 1994
Laboratory monitoring of warfarin therapy in UtahS B Garr, G M Rodgers
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 22, 2014
Continuous infusion of human plasma-derived von Willebrand factor concentrate as an effective therapy in a patient with acquired von Willebrand diseaseS B Patel, G M Rodgers
Thrombosis Research|November 1, 1992
Comparison of functional and antigenic fibrinogen values from a normal populationG M Rodgers, S B Garr
American Journal of Hematology|January 5, 2002
Update on selected inherited venous thrombotic disordersR S Robetorye, G M Rodgers
Pageof 11

Showing results (21-30 of 106) with videos related to

Sort By:
Pageof 11
American Journal of Clinical Pathology|August 1, 1996
Utilization of testing for activated protein C resistance in a reference laboratoryS R Florell, G M Rodgers
American Journal of Hematology|September 2, 1998
Disseminated intravascular coagulation: clinical and laboratory aspectsM J Carey, G M Rodgers
American Journal of Hematology|October 1, 1992
Laboratory and clinical aspects of inherited thrombotic disordersG M Rodgers, W L Chandler
Journal of Thrombosis and Haemostasis : JTH|April 29, 2015
Acute renal failure is prevalent in patients with thrombotic thrombocytopenic purpura associated with low plasma ADAMTS13 activity: commentM J Bentley, G M Rodgers
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1983
Prothrombin is activated on vascular endothelial cells by factor Xa and calciumG M Rodgers, M A Shuman
American Journal of Hematology|August 1, 1991
Lack of response to commercial factor VIII concentrate in hemophilia AG M Rodgers, M H Ford
American Journal of Hematology|January 1, 1994
Laboratory monitoring of warfarin therapy in UtahS B Garr, G M Rodgers
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 22, 2014
Continuous infusion of human plasma-derived von Willebrand factor concentrate as an effective therapy in a patient with acquired von Willebrand diseaseS B Patel, G M Rodgers
Thrombosis Research|November 1, 1992
Comparison of functional and antigenic fibrinogen values from a normal populationG M Rodgers, S B Garr
American Journal of Hematology|January 5, 2002
Update on selected inherited venous thrombotic disordersR S Robetorye, G M Rodgers
Pageof 11